Ads
related to: 7 biotech stocks to buy now- Bull & Bear 3X ETFs
Fixed Income, International Equity
Market Cap And Sector Equity
- Pharma ETF
Direxion Pharma & Medical ETF
Daily Bull 3X Shares - PILL
- Healthcare ETF
Direxion Daily Healthcare ETF
Bull 3X Shares ETF - CURE
- ETF Line-up
View Direxion's Complete List of
Leveraged and Inverse ETFs.
- ETF Education
View Our Educational Library to
Learn More About Our Products.
- Education
Articles, videos & tools to help
understand Leveraged ETFs and more.
- Bull & Bear 3X ETFs
Search results
Dow Jones Futures Fall; Toast Leads 5 New Buys; Robinhood, Arm Are Earnings Movers
Investor's Business Daily· 6 days agoCEG stock climbed 3.7% to 208 on Wednesday, moving toward the edge of the buy zone from a short flat...
CompoSecure (NASDAQ:CMPO) Price Target Raised to $10.00
ETF DAILY NEWS· 5 days agoCompoSecure (NASDAQ:CMPO – Free Report) had its price objective lifted by Benchmark from $8.00 to $10.00 in a research note released on Tuesday morning, Benzinga reports. The brokerage currently ...
7 Stocks That Ordinary Investors Can't Get Enough Of Right Now
InvestorPlace· 5 days agoIn an ecosystem where individuality is celebrated and groupthink is criticized, it may seem...
Centuri Holdings, Inc. (NYSE:CTRI) Given Consensus Rating of “Hold” by Analysts
ETF DAILY NEWS· 2 days agoTwo equities research analysts have rated the stock with a hold rating and one has issued a buy...
Alphabet Bought Up Two Slumping Stocks
Barrons.com· 3 days agoThe stock is down nearly 20% so far in the second quarter. The biotech, which focuses on gene-editing therapies, received gross proceeds of $161 million...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 6 days agoNeurocrine stock is forming a flat base with a buy point at 148.37, MarketSurge chart analysis...
Enhabit, Inc. to Post Q3 2024 Earnings of $0.04 Per Share, Leerink Partnrs Forecasts (NYSE:EHAB)
ETF DAILY NEWS· 5 hours agoLeerink Partnrs analyst W. Mayo now anticipates that the company will post earnings of $0.04 per share for the quarter, up from their prior estimate of $0.03. Leerink Partnrs ...
BioCryst Pharmaceuticals (NASDAQ:BCRX) Earns “Buy” Rating from Needham & Company LLC
ETF DAILY NEWS· 5 days agoNeedham & Company LLC reissued their buy rating on shares of BioCryst Pharmaceuticals (NASDAQ:BCRX – Free Report) in a research note published on Tuesday morning, Benzinga ...
The Goldman Sachs Group Lowers Match Group (NASDAQ:MTCH) Price Target to $37.00
ETF DAILY NEWS· 2 days agoMatch Group (NASDAQ:MTCH – Free Report) had its price target trimmed by The Goldman Sachs Group from $47.00 to $37.00 in a report released on Thursday, Benzinga reports. The firm currently has ...
Cathie Wood Is Buying This Under-the-Radar AI Stock
Motley Fool via Yahoo Finance· 3 days agoThe biotech shouldn't make a much bigger percentage of anyone's portfolio, even those of aggressive investors. Should you invest $1,000 in Recursion...
